*Min-Ho Nam1,2, Hae Young Ko4, Sangwon Lee4, Hoon Ryu1, Mijin Yun4, C. Justin Lee3 (1. Brain Science Institute, Korea Institute of Science and Technology, Seoul, Korea, 2. KHU-KIST Department of Convergence Science and Technology, Kyung Hee University, Seoul, Korea, 3. Center for Cogntion and Sociality, Institute for Basic Science, Daejeon, Korea, 4. Department of Nuclear Medicine, Yonsei University School of Medicine, Seoul, Korea)
Session information
Oral
[4O05m2] Neurodegenerative Disorders 3
Sun. Jul 3, 2022 10:00 AM - 11:00 AM Room 5 (Conference Building B2 (Okinawa Convention Center))
Chair: HIDEYUKI TAKEUCHI
*Keita Kakuda1, Kensuke Ikenaka1, César Aguirre1, Junko Doi1, Chi-Jing Choong1, Yasuyoshi Kimura1, Hideki Mochizuki1 (1. Osaka University)
*Takuya Ikeda1, Keita Takahashi1, Shunta Hashiguchi1, Misako Kunii1, Kenichi Tanaka1, Mikiko Tada1, Hiroshi Doi1, Hideyuki Takeuchi1, Kohtaro Takei2, Fumiaki Tanaka1 (1. Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 2. Molecular Medical Bioscience Laboratory, Yokohama City University Graduate School of Medical Life Science)
*Kei Hashimoto1, Seiji Watanabe1, Okiru Komine1, Akira Sobue1, Hiroaki Kamishina2, Yoshiaki Furukawa3, Koji Yamanaka1 (1. Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Aichi, Japan, 2. Clinical Radiology, Joint Department of Veterinary Medicine, Gifu University, Gifu, Japan, 3. Mechanistic Chemistry for Biomolecules, Department chemistry, Keio University, Kanagawa, Japan)